FFA
RGNX icon

Farther Finance Advisors’s Regenxbio RGNX Stock Holding History

Farther Finance Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Sell
148
-220
-60% -$1.83K ﹤0.01% 5201
2026
Q1 		$3.18K Sell
368
-51
-12% -$536 ﹤0.01% 4712
2025
Q4 		$6.03K Buy
419
+399
+1,995% +$4.97K ﹤0.01% 4200
2025
Q3 		$193 Buy
+20
New +$177 ﹤0.01% 4724
2025
Q2 		– Sell
-2,382
Closed -$16.1K – 4632
2025
Q1 		$16.1K Buy
+2,382
New +$17.7K ﹤0.01% 2494
2024
Q4 		– Sell
-33
Closed -$346 – 4124
2024
Q3 		$346 Hold
33
– – ﹤0.01% 3515
2024
Q2 		$365 Hold
33
– – ﹤0.01% 3347
2024
Q1 		$710 Buy
33
+22
+200% +$391 ﹤0.01% 2906
2023
Q4 		$197 Buy
+11
New +$194 ﹤0.01% 3228

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Farther Finance Advisors's RGNX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Regenxbio (RGNX) stake by 60% in Q2 2026, selling an estimated $1.83K and leaving 148 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #5201.

Farther Finance Advisors first reported a position in RGNX in Q4 2023 and has held it in 9 quarters since. The position peaked at $16.1K in Q1 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Farther Finance Advisors held 148 shares of Regenxbio worth $1.77K as of Q2 2026.
  • Farther Finance Advisors sold 220 Regenxbio shares in Q2 2026, an estimated $1.83K.
  • Regenxbio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5201 holding.
  • Farther Finance Advisors first reported a position in Regenxbio in Q4 2023 and has held it in 9 quarters since.
  • Farther Finance Advisors's Regenxbio position peaked at $16.1K in Q1 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.